A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
- Rowe, Dominic (Primary Chief Investigator)
- Gan, Richard (Research Coordinator)
- Ordonez Artunduaga, Paula (Research Coordinator)
Project: Research